
Prof. Marcello Deraco
IRCCS National Cancer Institute Foundation, Milan
Co-Director of European School of Peritoneal Surface Oncology (ESPSO)
President of Italian Society of Surgical Oncology (SICO)

Prof. Paolo Sammartino
University La Sapienza, Rome

Prof. Mohammed Alyami
Batterjee Medical College

Dr. Alvaro Arjona Sanchez
Hospital Universitario Reina Sofia

Dr. Omer Aziz
Manchester Academic Health Science Centre Honorary Clinical Chair

Prof. Brian Badgwell
The University of Texas MD Anderson Cancer Center, Houston, TX

Prof. Dario Baratti
Milan

Dr. Aditi Bhatt
Dept. of Surgical Oncology, KD Hospital

Dr. Lana Bijelic
Moises Broggi University Hospital, Barcelon and European School of Peritoneal Surface Malignancies

Dr. Donald Brennan
UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland

Prof. Maurizio Cardi
University of Sapienza, Rome

Dr. Pedro Cascales
Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Spain

Dr. Patrck Caswell
Wellcome Trust Centre for Cell-Matrix Research Manchester

Prof. Wim Ceelen
Department of surgical oncology, Ghent University, Belgium

Dr. Bipasha Chakrabarty
The Christie NHS Foundation Trust Wilmslow Road Manchester

Dr. Claramae Chia Shulyn
National Cancer Centre Singapore & Singapore General Hospital
Duke-NUS Graduate Medical School
Yong Loo Lin School of Medicine, National University of Singapore

Prof. Jean Marc Classe
President of the French Society of Surgical Oncology

Delia Cortés Guiral
IVOQA director (Oncologic Advanced Surgery Viamed Institute), Madrid, Spain

Prof. Giovanni De Manzoni
Faculty of Medicine, University of Verona

Prof. Ruggero De Maria
Alliance Against Cancer (ACC), Rome
Italian Institute for Genomic Medicine, Turin
Policlinico Universitario A. Gemelli IRCCS Foundation, Rome
University Cattolica del Sacro Cuore, Rome

Dr. Clarisse Dromain
Department of diagnostic and interventional radiology, Lausanne University Hospital

Dr. Jesus Esquivel
Frederick Memorial Hospital in Maryland

Dr. Clarisse Eveno
French Institute f Health and Medical Research Inserm

Dr. Anna Fagotti
A. Gemelli IRCCS University Polyclinic Foundation, Rome

Dr. Massimo Framarini
AUSL della Romagna Presidio of Forlì

Dott.ssa Roberta Gelmini
Oncological and Emergency Surgery Unit Policlinico of Modena University of Modena and Reggio Emilia - Italy

Dr. Diane Göéré
Department of Digestive and Oncological Surgery Hôpital Saint-Louis - Assistance Publique - PARIS

Prof. Marcello Guaglio
IRCCS National Cancer Institute Foundation, Milan

Prof. Martin Hübner
Department of Visceral Surgery
Lausanne University Hospital

Dr. Vahan Kepenekian
Hospital Lyon Sud

Dr. Edward Levine
Surgical Oncology Cancer Center Winston-Salem

Dr. Yan Li
Beijing Shijitan Hospital, Capital Medical University

Dott.ssa Rea Lo Dico
San Camillo Hospital, Rome Italy; Unité INSERM U1275 / CAP - Paris

Prof. Antonio Macrì
University of Messina, Italy

Pr. Brendan Moran
Institute, Basingstoke Hospital, Aldermaston Road, Basingstoke, UK

Dr. Aviram Nissan
The Chaim Sheba Medical Center Tel Hashomer, Ramat Gan, Israel

Dr. Carmine Pinto
AUSL of Reggio Emilia

Dr. Pompiliu Piso
Department for General and Visceral Surgery, Hospital Barmherzige Brueder Regensburg, Germany

Prof. Marc Pocard
Université Paris Cité - Paris France
INSERM U1275 CAP Paris Tech - Paris France

Dr. Beate Rau
Charité – University of Berlin and Hannover

Dr. SP Somashekhar
Aster International Institute of Oncology - GCC & India

Prof. Antonio Sommariva
Veneto Institute of Oncology IOV-IRCCS Surgical Oncology of the Esophagus

Prof. Cem Terzi
Colorectal Surgery Centre
Acıbadem Kent International Hospital
İzmir, Turkey

Dr. Kurt Van der Speeten
Hasselt University

Dr. Vic Verwaal
Skåne University hospital Malmö Sweden

Dr. Laurent Villeneuve
French network for the treatment of rare peritoneal malignancies (RENAPE), International Society for the Study of Pleura and Peritoneum (ISSPP)

Dr. Yutaka Yonemura
Center, Kishiwada Tokushukai Hospital. Representative, Japanese/Asian School of Peritoneal Surface Malignancy Treatment.

Dr. Nadia Zaffaroni
IRCCS National Cancer Institute Foundation